Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.

Neuropsychiatric disorders related to interferon and interleukins treatment

Abstract

Certain cytokines such as interferon-alpha and interleukin-2 are often used in the treatment certain cancers and chronic diseases such as melanoma, hepatitis C infection and multiple sclerosis. Several neuropsychiatric side effects such as depression, anxiety, psychosis, suicidal ideation, hypomanic mood and cognitive impairment were reported in those patients who received those medications. In certain patients with those neuropsychiatric side effects, the symptoms ceased when the medication was stopped. However, in some cases, the cognitive impairment persisted even for years after cessation of the medication. In animal studies, those cytokines could induce sickness behaviour, anxiety behaviour and social anhedonia. The increased in pro-inflammatory cytokines in certain neuropsychiatric disorders was widely reported. In addition, in animal studies, the treatment with interferon-alpha or interleukin-1 could induce depressive like behaviour. Recently, the role of certain pro-inflammatory cytokines that could enhance the activity of the enzyme, indoleamine 2-3, dioxygenase (IDO) which in turn would increase tryptophan degradation into kynurenine and decrease tryptophan availability of tryptophan in the brain to synthesize serotonin, a neurotransmitter which is necessary for the normal mood state became of interest in pathophysiology of psychiatric disorders. Furthermore, the imbalance in the further downward catabolic kynurenine pathway and their interactions with other neurotr…

Overview

Integrity signals

Registry

Crossref · 10.1007/s11011-008-9114-5

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 123 references

Cited by

See all 116

Metadata

Authors
Myint, A. M., Schwarz, M. J., Steinbusch, H. W. M., & Leonard, B. E.
Affiliations
  • Maastricht University (NL)
  • Ludwig-Maximilians-Universität München (DE)
Corresponding author
Myint, Aye Mu
Venue
Metabolic Brain Disease
Published
2008-12-10
Volume
24
Issue
1
Pages
55-68
ISSN
  • 0885-7490 (ISSN-L)
  • 1573-7365
OpenAlex
W2085486223
Cited by
116
References
123
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 6 · 2017: 4 · 2016: 6 · 2015: 10 · 2014: 7 · 2013: 9 · 2012: 11
FWCI
0.78
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Metabolic Brain Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
interferon-alpha, interleukin-2, interleukin-1, depression, anxiety, psychosis, suicidal ideation, hypomania, cognitive impairment, sickness behavior, social anhedonia, inflammatory cytokines, indoleamine 2,3-dioxygenase, tryptophan metabolism, kynurenine pathway, serotonin, neuroprotection, cancer immunotherapy adverse effects
MeSH terms
Animals, Mental Disorders, Brain, Brain Diseases, Metabolic, Encephalitis, Humans, Interferons, Interleukins, Kynurenine, Tryptophan, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuropsychiatric disorders related to interferon and interleukins treatment. https://app.cochat.ai/papers/10.1007/s11011-008-9114-5
The paper
Myint, A. M., Schwarz, M. J., Steinbusch, H. W. M., & Leonard, B. E. (2009). Neuropsychiatric disorders related to interferon and interleukins treatment. Metabolic Brain Disease. https://doi.org/10.1007/s11011-008-9114-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.